Patent US4438198A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4438198A Expired / Lapsed US ⏱️ 0.0 years remaining

Biochemically active matrix for use in a bio-artificial organ

Assignee: BIOMEDICS Inc AN IL CORP
•
Filing: 1981-09-30
•
Granted: 1984-03-20
•
Expires: 2001-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biochemically active matrix for use in a bio-artificial organ is disclosed. The biochemically active matrix has an enzyme covalently bonded to a matrix of organochemically cross-linked fibrin. The matrix may be suspended in a medium of agarose which irreversibly solidifies below 37° C. The bio-artificial organ is useful for extracorporeal treatment of blood to remove excess substrate from the blood. .

Inventors

  • 👤 Gottfried Schmer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 23:22
CPC Classifications
C; C12; C12N; C12N11/00; C12N11/02; C12N11/10

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 59 words
A biochemically active matrix suitable for use in a bio-artificial organ comprising at least one biochemically active enzyme covalently bonded to the surface of a carrier matrix of organochemically cross-linked fibrin through a reactive group of the enzyme which is not essential for its enzymatic activity and suspended in a medium of agarose which irreversibly solidifies below 37° C.
Claim 2
Dependent Claim 59 words
A biochemically active matrix suitable for use in a bio-artificial organ comprising at least one biochemically active enzyme covalently bonded to the surface of a carrier matrix of organochemically cross-linked fibrin through a reactive group of the enzyme which is not essential for its enzymatic activity and suspended in a medium of agarose which irreversibly solidifies below 37° C.
Claim 3
Dependent Claim 23 words
The biochemically active matrix of claim 1 wherein the biochemically active enzyme is covalently bonded to the surface of the matrix by glutaraldehyde.
Claim 4
Dependent Claim 14 words
The biochemically active matrix of claim 1 wherein the biochemically active enzyme is L-asparaginase.
Claim 5
Dependent Claim 14 words
The biochemically active matrix of claim 1 wherein the biochemically active enzyme is urease.
Claim 6
Dependent Claim 14 words
The biochemically active matrix of claim 1 wherein the biochemically active enzyme is indolyl-3-alkane-α-hydroxylase.
Claim 7
Dependent Claim 18 words
The biochemically active matrix of claim 1 wherein said enzyme is asparaginase and is covalently bonded by glutaraldehyde.
Claim 8
Dependent Claim 88 words
A bio-artificial organ comprising: (a) a reactor housing defining an enclosed space with an inlet and an outlet, the inner surface of the housing being compatible with an extracorporeal blood flow; (b) a carrier matrix of organochemically cross-linked fibrin disposed within the reactor, said carrier matrix being suspended in a medium of agarose which gels irreversibly below 37° C.; and (c) a biochemically active enzyme covalently bonded to the surface of the matrix through a reactive group of the enzyme which is not essential for its enzymatic activity.
Claim 9
Dependent Claim 88 words
A bio-artificial organ comprising: (a) a reactor housing defining an enclosed space with an inlet and an outlet, the inner surface of the housing being compatible with an extracorporeal blood flow; (b) a carrier matrix of organochemically cross-linked fibrin disposed within the reactor, said carrier matrix being suspended in a medium of agarose which gels irreversibly below 37° C.; and (c) a biochemically active enzyme covalently bonded to the surface of the matrix through a reactive group of the enzyme which is not essential for its enzymatic activity.
Claim 10
Dependent Claim 22 words
The bio-artificial organ of claim 7 wherein the biochemically active enzyme is covalently bonded to the surface of the matrix by glutaraldehyde.
Claim 11
Dependent Claim 12 words
The bio-artificial organ of claim 7 the biochemically active enzyme is L-asparaginase.
Claim 12
Dependent Claim 17 words
The bio-artificial organ of claim 7 wherein the carrier matrix is disposed on a physical support means.

References Cited (Backward Citations)

US3639558A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-20 1987-09-19 1988-03-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-20 1991-09-19 1992-03-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-20 1995-09-19 1996-03-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag